News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Amol Akhade: The Seduction of Significance
Amol Akhade/hiranandanihospital.org
Aug 3, 2025, 16:01

Amol Akhade: The Seduction of Significance

Amol Akhade, Consultant Medical Oncologist at Suyog Cancer Clinics, shared a post on X:

“New Substack

The Seduction of Significance: Understanding the Hidden Rules of Trial Design – Interim Analyses, Alpha, Power and The ‘Split’

  • Why p < 0.05 isn’t enough
  • Why nominal p can mislead
  • Why trials fail not on biology, but on spreadsheets
  • with 8 examples of real trials

Read here.”

More posts featuring Amol Akhade on OncoDaily.

Amol Akhade cancer OncoDaily Oncology Substack The “Split”
Special Coverage
Voices
Aug 27, 2025, 06:55
Arjun K Ghosh Engages in Timely Discussion on Cardio Oncology
Voices
Aug 27, 2025, 06:41
Sanjit Agrawal Reflects on the Success of ABSICON 2025
Science
Aug 27, 2025, 06:33
Alireza Mansouri Highlights a Trial on Immunotherapy in Newly Diagnosed Glioblastoma
Voices
Aug 27, 2025, 06:23
Kenyan Network of Cancer Organizations Hosts Africa Cancer Research and Control ECHO Review
Drugs
Aug 27, 2025, 06:17
Zanidatamab (Ziihera) Updates 2025: Uses in Cancer, Side Effects, Dosage, Expectations, and More
Science
Aug 27, 2025, 06:17
Robbe Heestermans Highlights cfDNA as a Tool for Liquid Biopsy in Multiple Myeloma
Opinion
Aug 27, 2025, 06:01
Omar Islam: Kicking off Breast Cancer Awareness Month with Breast AI Webinar
Voices
Aug 26, 2025, 19:43
ISLB25 Call for Research Submissions - International Society of Liquid Biopsy
Science
Aug 26, 2025, 19:35
Oscar Tahuahua: Lung Metastases - A Must-Read
Voices
Aug 26, 2025, 19:26
HT25: Tokyo Is Where Science Meets Impact - IASLC
Science
Aug 26, 2025, 19:21
Patrick Forde: A Graphic Research Summary for the CheckMate 816 Trial in NEJM
Science
Aug 26, 2025, 19:10
Jad Chahoud Shared Article on Cemiplimab Reducing Recurrence in High-Risk cSCC